Study to Evaluate the Pharmacokinetics & Food Effect of MK-0941 in Adults With Type 2 Diabetes (MK-0941-009)

• Status: Completed
• Trial end date: 2008-04-01
• Target enrollment: 0
• Participant gender: All

Summary

A study to compare the pharmacokinetics (PK) of the dry filled capsule (DFC) & oral compressed tablet (OCT) formulations of MK-0941-009 & to assess the effect of food on the OCT formulation.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.

Criteria

Inclusion Criteria:

• Males or females (of non-childbearing potential) between the ages of 18 to 70

• Participants have been diagnosed with Type 2 Diabetes

• Participants are nonsmokers for at least 6 months

Exclusion Criteria:

• Participant should not be diagnosed with Type 1 diabetes

• Participant should not be receiving insulin or PPAR gamma agonists for 12 weeks prior to study start

• Participant has a recent history of eye infection or other inflammatory eye condition within 2 weeks prior to study start

• Participant has been diagnosed with glaucoma or is blind

• Participant has had trauma to one or both eyes

• Participant has had major surgery, donated blood or participated in another clinical study in the past 4 weeks

• Participant is a regular user of illicit drugs or has a history of drug, including alcohol, abuse in the past 6 months